Dynamics Special Purpose Corp. (DYNS)
Price:
7.51 USD
( - -0.49 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Apex Technology Acquisition Corporation
VALUE SCORE:
6
2nd position
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
11
The best
Horizon Kinetics SPAC Active ETF
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Dynamics Special Purpose Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in Redwood City, California.
NEWS
Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
globenewswire.com
2022-01-06 08:02:00SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (“Senti Bio”), a leading Gene Circuit company today announced that Tim Lu, MD, PhD, Chief Executive Officer and Co-Founder, will present a corporate overview at the 40th Annual J.P. Morgan Virtual Healthcare Conference on Tuesday, January 11, 2022 at 2:00 p.m. EST.
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
benzinga.com
2021-12-20 14:21:14Senti Biosciences Inc, the synthetic biology play helmed by MIT whiz Tim Lu, will be merging with Farokhzad's Dynamics Special Purpose Corp (NASDAQ: DYNS) in a deal set to deliver $296 million in gross proceeds. Senti Bio uses its Gene Circuit platform to program cell and gene therapies with potentially enhanced capabilities.
Cathie Wood Makes Adjustments to Portfolio in August
gurufocus.com
2021-09-13 12:47:51Catherine Wood (Trades, Portfolio) disclosed last week her firm, ARK Investment Management, made a number of changes to its portfolio in August.
U.S. IPO Weekly Recap And Week Ahead
seekingalpha.com
2021-05-29 23:23:00U.S. IPO Weekly Recap And Week Ahead
No data to display
Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
globenewswire.com
2022-01-06 08:02:00SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (“Senti Bio”), a leading Gene Circuit company today announced that Tim Lu, MD, PhD, Chief Executive Officer and Co-Founder, will present a corporate overview at the 40th Annual J.P. Morgan Virtual Healthcare Conference on Tuesday, January 11, 2022 at 2:00 p.m. EST.
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
benzinga.com
2021-12-20 14:21:14Senti Biosciences Inc, the synthetic biology play helmed by MIT whiz Tim Lu, will be merging with Farokhzad's Dynamics Special Purpose Corp (NASDAQ: DYNS) in a deal set to deliver $296 million in gross proceeds. Senti Bio uses its Gene Circuit platform to program cell and gene therapies with potentially enhanced capabilities.
Cathie Wood Makes Adjustments to Portfolio in August
gurufocus.com
2021-09-13 12:47:51Catherine Wood (Trades, Portfolio) disclosed last week her firm, ARK Investment Management, made a number of changes to its portfolio in August.
U.S. IPO Weekly Recap And Week Ahead
seekingalpha.com
2021-05-29 23:23:00U.S. IPO Weekly Recap And Week Ahead